Drug Discovery

actavis-new-drug-application-nda-for-progestin-only-transdermal-contraceptive-patch-norethindrone-transdermal-delivery-system-gets-fda-nod

Actavis 'pregnancy preventer' gets FDA nod

  • US
  • |
  • News

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more

gilead-leukemia-study-gets-complete-repsonse

Gilead leukemia study gets complete response


  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more

bioduro-opens-discovery-lab-in-shanghai

BioDuro opens discovery lab in Shanghai


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more

good-news-for-glaucoma-patients-novartis-eye-care-firm-alcon-gets-us-fda-approval-for-elevated-intraocular-pressure-drug-simbrinza

FDA nod for Novartis eyecare firm's glaucoma drug

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Alcon, the global leader in eye care and a division of Novartis, has recieved US FDA approval for Simbrinza suspension, indicated... Read more

orchid-allecra-to-develop-antibiotics-to-combat-multi-drug-resistant-bacterial-infections

India, EU firms fight 'epidemic of drug-resistance'

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: India-based Orchid Pharma entered into a strategic partnership with Europe-based Allecra Therapeutics to develop novel antibiotics... Read more

good-news-for-chronic-obstructive-pulmonary-disease-copd-patients-glaxosmithkline-gsk-and-theravance-s-breo-ellipta-gets-us-fda-approval

GSK, Theravance COPD drug gets FDA nod

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Theravance's Breo Ellipta... Read more

bristol-myers-squibb-bms-to-use-santaris-pharma-s-proprietary-locked-nucleic-acid-lna-drug-platform-for-drug-discovery

BMS uses Santaris platform for drug discovery

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Santaris Pharma, a privately held biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs... Read more

chipscreen-gets-sfda-nod-after-accelerated-review

Chipscreen gets SFDA nod after accelerated review

  • China
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, registrational phase... Read more

dr-john-vernachio-the-new-vice-president-research-of-arthritis-foundation

John Vernachio is Arthritis Foundation research VP

  • US
  • |
  • Influencers
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Arthritis Foundation appointed Dr John Vernachio as vice president of research, effective April 15. In his new role he will provide... Read more

study-new-discovery-may-enhance-hiv-gene-therapy

GRPE elements to help cure HIV via gene therapy

Singapore: A research team from Case Western Reserve University School of Medicine has discovered an approach that could make gene therapy... Read more

mosquito-infection-with-a-new-strain-of-wolbachia-bacteria-called-wmelpop-prevents-them-from-laying-eggs-and-spreading-diseases-such-as-dengue-yellow-fever-and-malaria

Infect mosquitoes with Wolbachia, stop diseases

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected with the bacteria... Read more

patrys-conducts-treatment-of-another-patient-group-in-multiple-myeloma-trial

Patrys' 2nd group concludes treatment in Germany

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Patrys completed initial treatment of second group of three patients in its phase I/IIa PAT-SM6 multiple myeloma trial. The... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X